Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Mar 13:2017:bcr2016219160.
doi: 10.1136/bcr-2016-219160.

Severe hypophosphataemia after intravenous iron administration

Affiliations
Case Reports

Severe hypophosphataemia after intravenous iron administration

Gurpreet Anand et al. BMJ Case Rep. .

Abstract

Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Hempel EV, Bollard ER. The evidence-based evaluation of iron deficiency anemia. Med Clin North Am 2016;100:1065–75. 10.1016/j.mcna.2016.04.015 - DOI - PubMed
    1. Okada M, Imamura K, Fuchigami T et al. . 2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide. Nippon Naika Gakkai Zasshi 1982;71:1566–72. 10.2169/naika.71.1566 - DOI - PubMed
    1. Schouten B, Hunt P, Livesey J et al. . FGF23 elevation and hypophosphatemia after intravenous iron polymaltose. JCEM 2009;94:2332–7. - PubMed
    1. Shimizu Y, Tada Y, Yamauchi M et al. . Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 2009;45:814–16. 10.1016/j.bone.2009.06.017 - DOI - PubMed
    1. Van Wyck DB, Mangione A, Morrison J et al. . Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding. Transfusion 2009;49:2719–28. 10.1111/j.1537-2995.2009.02327.x - DOI - PubMed

Publication types